BDBM72376 MLS000662691::N-(2,6-dimethylmorpholin-4-yl)carbothioylcyclohexanecarboxamide::N-(2,6-dimethylmorpholine-4-carbothioyl)cyclohexanecarboxamide::N-[(2,6-dimethyl-4-morpholinyl)-sulfanylidenemethyl]cyclohexanecarboxamide::N-[(2,6-dimethyl-4-morpholinyl)carbonothioyl]cyclohexanecarboxamide::SMR000270130::cid_2909538

SMILES N#Cc1cc2c(cc1F)C(=O)N1CN2c2ccc(OC(F)(F)F)c(F)c2CNCCc2[nH]c(=O)ccc21

InChI Key InChIKey=JRKJQUYIEBLXTQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72376   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72376BDBM72376(Step A: 2,9-Difluoro-15,19-dioxo-8-(trifluorometho...)
Affinity DataIC50: 7.94nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent